Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 188 entries
View as:

Comparative Evaluation of Osteopathy Treatment Efficacy in Pain Support After Breast Surgery in Oncology

Phase: N/A Priority: Normal
NCT ID: NCT01403168 Org: User:
Start: 04/30/11 End: 04/30/15 Due: 04/30/16

Immunomonitoring of Children With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01295762 Org: User:
Start: 05/31/11 End: 07/31/19 Due: 07/31/20

Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6

Phase: N/A Priority: Normal
NCT ID: NCT03356223 Org: User:
Start: 02/05/18 End: 12/05/22 Due: 12/05/23

A Study to Assess Placement and Confirmation of Peripheral Inserted Central Catheters Tip Position Using a New Electrocardiographic Method

Phase: N/A Priority: Normal
NCT ID: NCT01969981 Org: User:
Start: 10/31/13 End: 04/30/14 Due: 04/30/15

Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT03818685 Org: User:
Start: 07/02/19 End: 05/01/24 Due: 05/01/25

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

Phase: N/A Priority: Normal
NCT ID: NCT04070443 Org: User:
Start: 11/13/19 End: 06/01/29 Due: 06/01/30

Study of the Impact of Everolimus Treatment on Lymphocytes NK (Natural Killer) Development and Functions for Patients With a Metastatic Breast Cancer (HR+ / HER2/Neu Negative)

Phase: N/A Priority: Normal
NCT ID: NCT02536625 Org: User:
Start: 10/31/15 End: 12/31/19 Due: 12/31/20

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

Phase: N/A Priority: Normal
NCT ID: NCT02730923 Org: User:
Start: 04/30/16 End: 12/31/24 Due: 12/31/25

Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01541072 Org: User:
Start: 02/29/12 End: 09/30/14 Due: 09/30/15

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02489695 Org: User:
Start: 10/31/15 End: 07/31/19 Due: 07/31/20

Implementation of a Program Based on Adapted Physical Activity and Recommendations for Second Cancers Prevention for TYACs

Phase: N/A Priority: Normal
NCT ID: NCT03336905 Org: User:
Start: 11/09/16 End: 04/30/19 Due: 04/30/20

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Phase: N/A Priority: Normal
NCT ID: NCT00291369 Org: User:
Start: 12/31/99 End: 02/28/05 Due: 02/28/06

Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT05588700 Org: User:
Start: 01/14/25 End: 01/14/38 Due: 01/14/39

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Phase: N/A Priority: Normal
NCT ID: NCT04741438 Org: User:
Start: 03/30/21 End: 08/31/25 Due: 08/31/26

Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01308034 Org: User:
Start: 03/31/11 End: 09/21/16 Due: 09/21/17

BENdamustine at Elevated Dose for Relapsed Follicular Lymphoma in Intensification Therapy and Transplantation (BENEFIT)

Phase: N/A Priority: Normal
NCT ID: NCT02008006 Org: User:
Start: 07/09/14 End: 07/12/18 Due: 07/12/19

Trial Evaluating Hypnosis Using Virtural Reality vs Standard Pain Management During Musculoskelettal Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT03418597 Org: User:
Start: 01/31/18 End: 05/16/18 Due: 05/16/19

Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)

Phase: N/A Priority: Normal
NCT ID: NCT02014831 Org: User:
Start: 02/29/16 End: 02/29/16 Due: 02/28/17

Efficacy of Cryotherapy Combined or Not With Analgesics in Uncontrolled Painful Musculoskeletal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT03441139 Org: User:
Start: 07/19/18 End: 08/30/20 Due: 08/30/21

Study Evaluating the Parent-child Relationship During the Hospitalisation of a Parent in Long-term Protective Isolation

Phase: N/A Priority: Normal
NCT ID: NCT04856332 Org: User:
Start: 02/24/21 End: 06/03/23 Due: 06/03/24

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Phase: N/A Priority: Normal
NCT ID: NCT04193553 Org: User:
Start: 01/17/20 End: 04/26/24 Due: 04/26/25

Feasibility of an Acute Physical Exercise Before Treatment Infusion for Metastatic Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04676009 Org: User:
Start: 01/21/21 End: 01/11/24 Due: 01/11/25

Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00416871 Org: User:
Start: - End: 02/28/06 Due: 02/28/07

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT04055220 Org: User:
Start: 03/03/20 End: 10/01/26 Due: 10/01/27

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06706401 Org: User:
Start: 02/20/25 End: 01/31/29 Due: 01/31/30